Mediwound Ltd

NASDAQ MDWD

Data sourced from iex and EODHD
Download Data

Mediwound Ltd Income Statement 2012 - 2024

This table shows the Income Statement for Mediwound Ltd going from 2012 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31
Revenue
M 5 5 5 5 4 12 6 5 4 5 6 6 6 7 7 4 4 5 5 21 0 1 1 1 1 1 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue
M 4 5 4 4 3 3 3 4 3 4 4 4 3 4 4 3 3 4 4 3 0 1 0 1 0 0 0 0 0 1 0 0 0 1 1 1 0 1 1 1 0 2 2 2 1 2
Gross Profit
M 1 1 1 1 1 8 2 1 1 2 2 2 2 2 3 1 1 1 1 17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 -1 0 -1 -1 -1 0 0 0 0 0 0
Operating Expenses
M 4 5 4 5 5 6 6 4 5 5 5 5 4 5 4 4 3 4 3 3 4 -5 3 4 4 4 3 4 4 4 5 7 4 6 4 5 4 6 5 4 4 2 2 2 1 0
Selling, General, and Administrative Expenses (SG&A)
M 3 7 3 3 3 1 3 1 2 5 2 2 2 2 2 2 2 2 2 1 1 2 1 1 1 2 1 1 1 3 1 1 1 4 1 1 1 1 1 1 1 0 0 0 0 0
Research and Development (R&D) Expenses
M 1 2 2 2 2 3 3 2 2 2 3 3 2 2 2 2 2 2 1 0 1 0 1 2 1 1 1 2 2 1 2 3 1 2 1 1 1 1 1 1 1 1 1 1 1 2
Other Operating Expenses
M 0 -4 0 0 0 3 0 1 0 -2 0 1 0 0 0 0 0 0 0 2 1 -7 1 1 2 0 1 1 1 0 2 3 2 0 2 3 2 3 2 2 2 1 1 0 0 -2
Costs and Expenses
M 4 0 0 2 2 3 3 1 2 1 1 2 1 0 0 1 0 0 -1 -1 3 -6 2 3 3 3 3 3 4 3 5 6 3 6 3 4 4 4 4 4 4 0 0 0 0 -2
Operating Income
M -4 -4 -3 -4 -4 2 -4 -3 -3 -4 -3 -3 -2 -2 -2 -3 -2 -3 -3 14 -4 5 -2 -3 -4 -4 -3 -4 -4 -5 -5 -7 -4 -7 -4 -6 -4 -7 -5 -5 -4 -2 -2 -2 -1 0
Interest Expense
M - 6 - 1 1 -2 1 1 0 1 0 0 1 0 0 0 0 0 0 1 1 2 1 1 1 2 1 1 1 1 1 1 0 1 0 0 2 1 1 1 1 0 1 2 1 0
Non-operating Income/Expense
M - 2 1 5 1 -9 -1 -1 0 -1 0 0 -1 1 0 0 0 -2 0 -1 0 7 -1 0 -1 1 -1 -1 -1 3 -1 -1 0 -1 1 1 -2 -1 0 -1 -1 1 0 -2 -1 0
EBT
M -10 -2 -2 1 -4 -7 -4 -4 -4 -4 -3 -3 -3 -2 -2 -3 -2 -4 -3 13 -4 6 -3 -4 -5 -2 -4 -4 -4 -2 -6 -8 -4 -8 -4 -4 -6 -7 -5 -6 -1 -1 -2 -3 -2 12
Income Tax Provision
M - 0 0 0 0 0 0 0 0 0 0 0 1 -1 0 0 0 1 -3 1 1 -13 1 1 1 -1 8 1 1 -3 1 1 0 1 -1 -1 2 1 0 1 1 -1 5 3 2 0
Income after Tax
M - -2 -2 1 -4 -7 -4 -4 -4 -4 -3 -3 -4 -1 -2 -3 -3 -5 0 11 -5 19 -4 -5 -6 -1 -12 -5 -5 1 -6 -8 -4 -9 -3 -3 -8 -8 -5 -7 -2 1 -7 -6 -4 12
Non-Controlling Interest
M - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -3 0 0 -5 0 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 -12
Net Income
M - - - - -4 -7 -4 -4 -4 -4 -3 -3 -3 -2 -2 -3 -2 -3 0 13 -4 11 -3 -4 -5 -16 -11 8 -4 -19 0 0 0 -22 0 0 0 -19 0 0 0 -15 0 0 0 12
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 9,491,718.00 9,219,923.00 9,217,000.00 9,209,000.00 8,388,000.00 6,333,000.00 4,783,142.00 4,734,285.00 4,104,714.00 3,892,571.00 3,892,142.00 3,891,571.00 3,891,000.00 3,887,571.00 3,882,714.00 4,020,779.00 3,887,285.00 3,882,714.00 3,882,714.00 3,882,714.00 3,882,714.00 3,882,714.00 3,882,714.00 3,864,571.00 3,864,000.00 3,864,000.00 3,205,428.00 3,135,142.00 3,132,857.00 3,127,264.00 3,122,428.00 3,121,428.00 3,121,428.00 3,114,428.00 3,114,428.00 3,096,000.00 3,078,571.00 3,070,996.00 3,042,571.00 3,042,571.00 2,249,857.00 142,454,102.00 2,907,226.00 2,907,226.00 2,907,226.00 -
EBITDA
M - -4 -3 -4 -4 -9 -3 -3 -3 -3 -3 -2 -2 -2 -1 -2 -2 -3 -2 14 -3 5 -2 -3 -4 -3 -3 -3 -3 -4 -5 -6 -3 -7 -3 -4 -4 -6 -4 -5 0 -1 -1 -2 -1 -
Depreciation and Amortization
M - 0 0 0 0 -11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
EBIT
M - -4 -3 -4 -4 2 -4 -3 -3 -4 -3 -3 -2 -2 -2 -3 -2 -3 -3 14 -4 5 -2 -3 -4 -4 -3 -4 -4 -5 -5 -7 -4 -7 -3 -4 -4 -7 -4 -5 0 -1 -2 -2 -1 0
Income from Discontinued Operations
M - - - - - - - - - - - - - 0 0 0 0 0 3 3 0 5 5 5 5 -8 -8 15 -8 -8 0 0 0 0 0 0 0 0 0 0 0 -7 0 0 0 0
Tax Rate (Effective)
% - -7.39 -2.23 1.29 -0.14 -0.88 -0.12 -0.09 -0.11 -0.10 -0.12 -0.60 -32.62 37.83 -18.34 -12.60 -10.36 -41.72 84.82 9.61 -14.90 -213.03 -23.91 -22.59 -31.58 51.26 -234.22 -17.01 -15.09 138.81 -13.43 -10.80 6.09 -12.21 15.85 34.70 -32.40 -7.16 4.11 -14.33 -109.52 274.44 -200.66 -81.06 -75.45 0.00
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Gross Profit Margin
% 12.23 13.47 18.76 23.82 21.74 70.22 41.94 23.84 33.13 28.05 38.53 38.98 41.32 34.89 41.81 30.25 27.72 19.88 14.12 83.22 33.41 30.24 55.01 38.99 26.73 21.51 54.26 29.55 37.04 -98.84 8.49 -19.38 -59.06 -158.05 -707.84 -403.64 -161.19 -820.97 -1,530.43 -1,753.85 -240.00 - - - - -
Operating Income Margin
% -75.22 -72.71 -63.34 -83.95 -114.87 15.61 -60.49 -72.09 -74.52 -64.17 -45.26 -47.80 -32.85 -35.76 -23.28 -67.20 -49.71 -57.77 -52.96 67.18 -776.36 532.26 -261.07 -318.72 -714.23 -664.91 -378.48 -539.01 -678.33 -1,048.14 -954.44 -1,882.02 -1,576.38 -2,558.05 -4,277.45 -3,373.33 -6,668.66 -5,311.29 -11,354.35 -13,207.69 -8,934.00 - - - - -
Net Income Margin
% - - - - -97.21 -64.18 -72.36 -93.27 -81.44 -75.82 -52.50 -52.75 -48.76 -25.96 -28.78 -76.88 -55.45 -63.27 -4.05 61.29 -891.54 1,068.85 -343.12 -403.98 -875.19 -2,972.64 -1,428.96 1,234.35 -798.89 -4,391.86 0.00 0.00 0.00 -8,272.66 0.00 0.00 0.00 -15,221.77 0.00 0.00 0.00 - - - - -
EBITDA Ratio
% - -66.22 -56.24 -77.35 -106.90 -75.48 -54.66 -71.42 -67.23 -59.14 -40.00 -40.58 -28.00 -32.40 -18.34 -60.47 -38.28 -52.24 -47.20 68.97 -703.69 545.36 -230.89 -291.08 -675.38 -639.06 -351.83 -505.09 -628.52 -1,000.93 -910.42 -1,814.89 -1,350.39 -2,500.75 -3,237.25 -2,303.64 -6,386.57 -5,196.77 -9,423.91 -12,707.69 346.00 - - - - -
EBIT Ratio
% - -72.71 -63.34 -83.95 -114.87 15.61 -60.49 -72.09 -74.52 -64.17 -45.26 -45.85 -32.67 -35.76 -23.28 -67.20 -44.32 -57.77 -52.96 67.63 -763.12 532.26 -247.44 -307.57 -701.35 -664.91 -369.15 -526.35 -657.41 -1,048.14 -936.10 -1,851.40 -1,398.82 -2,558.05 -3,354.90 -2,373.33 -6,558.21 -5,267.74 -9,750.00 -13,058.97 112.00 - - - - -
EBT Ratio
% -195.51 -30.40 -44.97 19.44 -97.08 -63.63 -72.27 -93.19 -81.35 -75.74 -52.43 -52.44 -48.76 -25.91 -30.04 -76.88 -55.45 -64.79 -57.67 61.29 -902.39 604.33 -343.12 -403.98 -875.19 -425.09 -474.15 -649.49 -798.89 -438.60 -1,102.51 -2,109.83 -1,485.83 -2,913.86 -3,692.16 -2,504.24 -8,944.78 -5,720.97 -10,906.52 -15,458.97 -1,470.00 - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email